Unique Clinically Relevant Prognostic Indicators After TIPS Placement in Cirrhosis Patients with Pre-Existing Kidney Disease
<b>Background</b>: Transjugular intrahepatic portosystemic shunt (TIPSS) outcomes in patients with moderate-to-severe pre-existing kidney disease (PKD, stages G3a-G4) remain poorly characterized. This study aimed to identify potential predictors of mortality specifically in patients with an eGFR 15-59 mL/min/1.73 m<sup>2</sup>. <b>Methods</b>: We retrospectively analyzed 68 cirrhosis patients with PKD (eGFR < 60 mL/min/1.73 m<sup>2</sup>) undergoing a TIPSS between April 2021 and April 2024. Clinical outcomes, renal function changes, and 12-month survival were assessed. Statistical analyses included paired <i>t</i>-tests with false discovery rate adjustment and Kaplan-Meier survival analysis to identify potential predictors of mortality. <b>Results</b>: The cohort (mean age 61.0 ± 8.3 years, 83.8% male, 79.4% with PKD G3a-G3b) showed modest improvement in renal function (creatinine 1.93 to 1.75 mg/dL, <i>p</i> = 0.031), though this biochemical change did not predict survival. Overall mortality was 36.8% (95% CI: 25.4-49.5%) at mean follow-up of 6.7 months. Traditional severity scores (MELD, Child-Turcotte-Pugh) showed no significant association with survival (<i>p</i> > 0.05 for all comparisons). In exploratory analyses, mortality was significantly higher in patients with the following: (1) uncontrolled diabetes before a TIPSS (55.2% vs. 25.9%; RR 2.35, 95% CI: 1.08-5.15, <i>p</i> = 0.032); (2) post-TIPSS infection (70.0% vs. 31.0%; HR 5.44, 95% CI: 1.54-19.23, <i>p</i> = 0.009); and (3) post-procedural cardiac events (85.7% vs. 31.1%; <i>p</i> = 0.005). These associations persisted after false-discovery rate adjustment but require prospective validation given the modest sample size and wide confidence intervals. <b>Conclusions</b>: In this exploratory single-center study of patients with moderate PKD undergoing a TIPSS, we observed associations between mortality and pre-TIPSS poorly controlled diabetes, infections, and cardiac events. These hypothesis-generating findings suggest potential areas for future research. Prospective multi-center studies are needed to validate these associations and determine whether interventions targeting these factors improve outcomes.
Authors
- Ajit K. Tharakan (ORCID: https://orcid.org/0000-0002-6430-2580)
- Tharun Tom Oommen (ORCID: https://orcid.org/0000-0003-0511-5002)
- A. Grace Baby (ORCID: https://orcid.org/0009-0006-1469-9934)
- Arif Hussain Theruvath (ORCID: https://orcid.org/0000-0002-3570-3465)
- Philip Augustine (ORCID: https://orcid.org/0000-0003-0787-0984)
- Cyriac Abby Philips (ORCID: https://orcid.org/0000-0002-9587-336X)
- Rajesh K Sasidharan
- Aryalakshmi Sreemohan (ORCID: https://orcid.org/0009-0004-6960-4627)
- Rizwan Ahamed
Institutions
- Rajagiri Hospital (IN)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-01-06
- DOI
- https://doi.org/10.3390/jcm15020414
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00